← Back to Search

Procedure

Catheter ablation with High Power Short Duration RF ablation settings for Atrial Fibrillation (Short-AF Trial)

N/A
Waitlist Available
Led By Edward P Gerstenfeld, MD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during ablation and up to 12 month follow up assessment
Awards & highlights

Short-AF Trial Summary

This trial will compare the effectiveness of two different types of radiofrequency ablation in treating atrial fibrillation.

Eligible Conditions
  • Atrial Fibrillation

Short-AF Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during ablation and up to 12 month follow up assessment
This trial's timeline: 3 weeks for screening, Varies for treatment, and during ablation and up to 12 month follow up assessment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Ablation Duration
Secondary outcome measures
% pulmonary vein pairs isolated with first encirclement
Freedom from Atrial Fibrillation
Maximum esophageal temperature
+10 more

Short-AF Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: High Power Short Duration (HPSD)Experimental Treatment1 Intervention
Group 2 - High power short duration RF
Group II: Standard Catheter SettingsActive Control1 Intervention
Group 1 - Standard RF ablation settings
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Catheter ablation with High Power Short Duration RF ablation settings
2019
N/A
~60

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor
2,505 Previous Clinical Trials
15,237,495 Total Patients Enrolled
11 Trials studying Atrial Fibrillation
19,064 Patients Enrolled for Atrial Fibrillation
Edward P Gerstenfeld, MDPrincipal InvestigatorChief of Cardiac Electrophysiology
1 Previous Clinical Trials
3,000 Total Patients Enrolled
1 Trials studying Atrial Fibrillation
3,000 Patients Enrolled for Atrial Fibrillation

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~11 spots leftby Apr 2025